Skip to main content

Advertisement

ADVERTISEMENT

Interviews

Interview
07/06/2010
An Interventional Radiology Laboratory’s Experience with the REEF HP PTA Balloon Catheter
An Interventional Radiology Laboratory’s Experience with the REEF HP PTA Balloon Catheter
An Interventional Radiology...
07/06/2010
Vascular Disease Management
Interview
05/27/2010

Christopher J. White, MD

Christopher J. White, MD
There is now more “texture” to the data, but the conclusion is still that there are no significant differences between the outcomes with carotid artery stenting (CAS) and carotid endarterectomy (CEA). In essence, there were more minor strokes...
There is now more “texture” to the data, but the conclusion is still that there are no significant differences between the outcomes with carotid artery stenting (CAS) and carotid endarterectomy (CEA). In essence, there were more minor strokes...
There is now more “texture” to...
05/27/2010
Vascular Disease Management
Interview
04/01/2010
The concept of dialysis dates back to the start of the 20th century. It was known that you could pass blood with various chemical impurities in it, which are the type that occur with kidney disease, through cellophane membranes with a salt...
The concept of dialysis dates back to the start of the 20th century. It was known that you could pass blood with various chemical impurities in it, which are the type that occur with kidney disease, through cellophane membranes with a salt...
The concept of dialysis dates...
04/01/2010
Vascular Disease Management
Interview
02/26/2010
CREST (Carotid Revascularization Endarterectomy versus Stent Trial) is a landmark trial which shows that endarterectomy and stenting for carotid artery stenosis appear to be comparable based on the primary endpoint of the trial: death, stroke...
CREST (Carotid Revascularization Endarterectomy versus Stent Trial) is a landmark trial which shows that endarterectomy and stenting for carotid artery stenosis appear to be comparable based on the primary endpoint of the trial: death, stroke...
CREST (Carotid Revascularization...
02/26/2010
Vascular Disease Management
Interview
02/02/2010

Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
 

Interview with Co-Principal Investiga...
Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
Interview with Co-Principal...
02/02/2010
Vascular Disease Management
Interview
09/05/2008
As new technologies and procedures are introduced, the question of what’s best for the patient is extremely important. Physicians must be clear about why they want to offer alternatives to the standard of care. Is there really no other option...
As new technologies and procedures are introduced, the question of what’s best for the patient is extremely important. Physicians must be clear about why they want to offer alternatives to the standard of care. Is there really no other option...
As new technologies and...
09/05/2008
Vascular Disease Management
Interview
09/05/2008
Right now, there aren’t enough experts in vascular medicine to care for the masses of patients who have systemic atherosclerosis. So many different specialists are involved in the care of these patients that it’s hard to know who really has...
Right now, there aren’t enough experts in vascular medicine to care for the masses of patients who have systemic atherosclerosis. So many different specialists are involved in the care of these patients that it’s hard to know who really has...
Right now, there aren’t enough...
09/05/2008
Vascular Disease Management
Interview
09/05/2008
What is the value of a comprehensive clinical program for the treatment of carotid artery disease?
What is the value of a comprehensive clinical program for the treatment of carotid artery disease?
What is the value of a...
09/05/2008
Vascular Disease Management
Interview
09/05/2008
Drug-eluting stents (DES) have revolutionized the treatment of obstructive coronary disease and expanding their applications to the periphery is inevitable. However, a better understanding of stent-associated restenosis in the periphery is...
Drug-eluting stents (DES) have revolutionized the treatment of obstructive coronary disease and expanding their applications to the periphery is inevitable. However, a better understanding of stent-associated restenosis in the periphery is...
Drug-eluting stents (DES) have...
09/05/2008
Vascular Disease Management
Interview
09/05/2008
The First International CLI Summit on Lower Extremity PVD and Critical Limb Ischemia: A Pre New Cardiovascular Horizons Event.
The First International CLI Summit on Lower Extremity PVD and Critical Limb Ischemia: A Pre New Cardiovascular Horizons Event.
The First International CLI...
09/05/2008
Vascular Disease Management

Advertisement

Advertisement

Advertisement